Alim alert: monsey firm of wohl & fruchter investigating fairness of the sale of alimera sciences to ani pharmaceuticals

Monsey, n.y., june 24, 2024 (globe newswire) -- the law firm of wohl & fruchter llp is investigating the fairness of the proposed sale of alimera sciences, inc. (nasdaq: alim) (“alimera”) to ani pharmaceuticals (“ani”) for $5.50 per share in cash, plus a contingent value right (cvr) of $0.50 per share upon the achievement of certain net revenue milestones.
ALIM Ratings Summary
ALIM Quant Ranking